Somos

What Somos does

Somos, operated by SuperGenix Inc. (DBA Somos Labs, Inc. and Somos Inc.), is a Portland, Oregon-based developer of virtual reality (VR) games for neuromotor and brain rehabilitation. Its flagship product, SignWave, is an FDA-listed VR rhythm game that translates clinically proven hand and wrist rehabilitation exercises (tendon glides, grip training) into a gameplay experience running on Meta Quest headsets using the platform's hand- and body-tracking technology. A second product, RoboArms — a mind-controlled suite of upper- and lower-extremity VR games — is in pre-clinical testing at Oregon Health & Science University (OHSU).

The company is positioned around clinical credibility: Somos is "built by clinicians, scientists, and game developers" and has secured pilot-study affiliations with Walter Reed National Military Medical Center, Johns Hopkins University Applied Physics Laboratory, the Uniformed Services University of the Health Sciences, and the Henry M. Jackson Foundation for the Advancement of Military Medicine. Pilot outcomes cited by the company include a 161.8% grip-strength gain and a 3x improvement in hand and wrist function versus traditional rehabilitation methods. Distribution is currently limited to the United States via the Meta Quest App Store and direct enterprise engagement with research and military hospitals.

Commercially, Somos is at a pre-revenue stage. SignWave is offered as a free beta in exchange for feedback, with commercial pricing not yet publicly disclosed; RoboArms has no commercial release date. Distribution runs through the Meta Quest consumer app marketplace (self-serve/PLG) alongside direct enterprise/pilot engagement with research and military hospitals. Marketing is largely organic — a website, Instagram, Facebook, and LinkedIn — augmented by cause-marketing efforts, including a Johns Hopkins ALS therapeutics fundraiser with Aaron Lazar. No funding rounds, investors, headcount figures, or paying customers are disclosed in the available data.

Name

Somos

Legal name

SuperGenix Inc.

Website

https://somosxr.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Somos develops FDA-listed VR neuromotor rehabilitation games for Meta Quest, including the SignWave hand/wrist rehab rhythm game (in open beta) and the in-development RoboArms mind-controlled rehab suite, targeting patients with neurological and motor conditions and partnering with leading U.S. military and research hospitals.

Ownership category

akta.pro rank

Product category

VR Rehabilitation Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYMPAFAGAG

VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)

Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)

Keywords

• VR rehabilitation software
• Neuromotor therapy games
• Digital health therapeutics
• Hand wrist rehab
• Medical VR applications

Headquarters

HQ city

Oregon City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SignWave Alpha Software: Currently in alpha testing phase with free beta program. Users provide feedback in exchange for free access. Revenue model for commercial release not yet specified.
2. RoboArms (Future Product): Product in development phase - revenue model to be determined.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Somos develops and sells VR-based neuro and motor rehabilitation games, primarily SignWave, an FDA-listed virtual reality rhythm game that transforms clinically proven hand and wrist neuromotor rehab exercises (tendon glides, grip training) into immersive gameplay on the Meta Quest headset using hand tracking technology without controllers. A second product, RoboArms, is a mind-controlled upper and lower extremity VR game suite currently in pre-clinical testing at OHSU. Both products target individuals recovering from neurological and motor conditions and are supported by pilot studies at leading research and military hospitals.

Product overview

Somos develops a portfolio of VR-based neuromotor and brain rehabilitation games. The primary product is SignWave, an FDA-listed virtual reality rhythm game that converts clinically proven hand and wrist exercises into an engaging gameplay experience for rehabilitation. A second product, RoboArms, is a mind-controlled upper and lower extremity VR game suite currently in pre-clinical testing. Both products target individuals with neurological and motor conditions requiring brain and body rehabilitation.

Differentiator

Problem solved

Functional benefit

Brands

• SignWave: VR hand and wrist rehabilitation rhythm game for neuromotor rehab, clinically proven and FDA-listed.
• RoboArms

Products and services

• SignWave FDA-listed virtual reality rhythm game that turns clinically proven hand and wrist neuromotor rehabilitation exercises (tendon glides, grip training) into an immersive, controller-free gameplay experience designed to rebuild fine motor dexterity and improve hand, wrist, and arm function. Targeted at individuals recovering from neurological and motor conditions such as stroke and ALS, and at clinical deployment via research and military hospital partners.
• RoboArms Mind-controlled suite of upper and lower extremity VR games for people on a healing journey from challenging neurological and motor conditions. Currently in pre-clinical testing at OHSU; intended as a future Somos rehabilitation product beyond SignWave.

Quantifiable outcome

• 161.8% grip strength gain and 3x improvement in hand and wrist function compared to traditional methods

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Johns Hopkins University Applied Physics LaboratorycoreStrategic or Co-development PartnerPilot study partner for SignWave research and clinical validation. Also partnered for first-of-its-kind ALS therapeutics clinical trial with Aaron Lazar.
• Oregon Health & Science University (OHSU)coreStrategic or Co-development PartnerPre-clinical testing site for RoboArms product. Partner in clinical research and validation of rehabilitation games.
• Walter Reed National Military Medical CentercoreStrategic or Co-development PartnerPilot study partner for SignWave. Clinical deployment site for military rehabilitation.
• Uniformed Services University of the Health SciencescoreStrategic or Co-development PartnerResearch partner for SignWave pilot studies and clinical validation.
• Henry M. Jackson Foundation for the Advancement of Military MedicinecoreStrategic or Co-development PartnerPilot study affiliation partner for SignWave clinical research.
• Aaron LazarminorOthersGrammy award nominee partnering with Somos to fundraise for first-of-its-kind ALS therapeutics clinical trial at Johns Hopkins.
• Meta Platforms, Inc.coreTechnology or IntegrationPlatform partner enabling SignWave distribution on Meta Quest devices. Meta provides VR platform, hand tracking technology, and App Lab distribution channel.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BehaVR: BehaVR develops VR-based digital therapeutics, primarily for mental health and chronic pain — a peer in the VR-therapeutics distribution model (Meta Quest) and clinical-evidence-driven go-to-market, though focused on behavioral indications.
• MindMaze: MindMaze is a Swiss-based digital neurotherapeutics company building VR-based neurorehabilitation platforms for stroke and brain injury patients — the closest functional analog to Somos's SignWave, with FDA-cleared products and hospital deployments.
• XRHealth: XRHealth operates a VR telehealth therapy platform spanning physical, cognitive, and mental health rehabilitation, distributing via Meta Quest and other headsets — overlapping directly with Somos's VR-rehab-on-Meta-Quest model.
• Penumbra (REAL Immersive System): Penumbra's REAL System is an FDA-cleared VR rehabilitation platform for stroke and upper-extremity recovery used in clinical settings — directly comparable to SignWave in target indication, regulatory pathway, and customer base.

Broad incumbents

• Saebo: Saebo is an established manufacturer of upper-extremity rehabilitation devices (splints, functional electrical stimulation) — serving the same patient population and clinical channel as Somos but with physical rather than digital products.
• Hinge Health: Hinge Health is a large digital musculoskeletal care platform combining sensor-guided exercise with coaching — adjacent to Somos in rehab modality and outcome-tracking philosophy, though focused on MSK pain rather than neurological recovery.
• Meta Reality Labs: Meta Reality Labs owns the Quest VR hardware platform and App Lab distribution channel that Somos depends on — a critical incumbent partner/ecosystem owner whose roadmap decisions materially shape Somos's market opportunity.
• Sword Health: Sword Health is a digital MSK and pelvic-health therapy platform using wearable sensors and AI — comparable as a tech-enabled rehabilitation platform targeting enterprise/payer customers, though in MSK rather than neuro indications.

Emerging players

• Neuro Rehab VR: Neuro Rehab VR builds VR games for physical and cognitive rehabilitation in clinical settings, directly comparable to SignWave's 'rehab-as-gameplay' approach, but at a smaller scale and narrower clinical footprint.
• Neurofenix: Neurofenix develops digital and VR-enabled stroke rehabilitation tools (e.g., NeuroBall) — comparable to Somos in target indication (post-stroke upper-extremity recovery) and clinical-channel GTM, though with a dedicated hardware accessory model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SomosXR
• LinkedInlinkedin.com/company/somosxr/posts/?feedView=all
• Instagraminstagram.com/somosxr
• Xx.com/somosxr

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Somos